Reported Aug 24, 2026 · Announced · Updated Sep 17, 2026
Vitruvias Therapeutics, Inc recalls Vitruvias Therapeutics Thyroid Tablets, USP 30 mg due to Potential for the Product to be Superpotent
Vitruvias Therapeutics, Inc.
Risk not classifiedThe agency has not ranked the risk yet — treat the notice as a caution.What you should do
Stop using the product and follow the return or refund instructions in the firm's announcement.
What it looks like
Is this the product you have?
- Thyroid Tablets
- USP 30 mg BrandVitruvias Therapeutics. Drugs
Why it was recalled
Potential for the Product to be Superpotent
The agency has not ranked the risk yet — treat the notice as a caution.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Vitruvias Therapeutics, Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.